RxDoctor Payments Data

Peter Milgrom

Dental Public Health · Seattle, WANPI 1407939689

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $291,606 of the $305,696 with a category attached, or 95.4%. Every reported general payment came from a single manufacturer, Elevate Oral Care. Reporting peaked in 2022 at $151,440 and has fallen 91.3% since, to $13,145 in 2025.

$305,696in general payments, 2019–2025

Across 55 payments — averaging $5558.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elevate Oral Care$306K
$429,424in research payments, 2019–2025

Across 64 payments — averaging $6709.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Elevate Oral Care$429K

What the payments were for

  • Consulting fees$13,1454%
  • Speaking & faculty fees$291,60695%
  • Travel & lodging$9300%
  • Food & beverage$150%

General payments by program year

20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Elevate Oral Care55$305,696

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few dental public health providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Other dental public health in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →